Literature DB >> 22535446

The adaptive immune response in celiac disease.

Shuo-Wang Qiao1, Rasmus Iversen, Melinda Ráki, Ludvig M Sollid.   

Abstract

Compared to other human leukocyte antigen (HLA)-associated diseases such as type 1 diabetes, multiple sclerosis, and rheumatoid arthritis, fundamental aspects of the pathogenesis in celiac disease are relatively well understood. This is mostly because the causative antigen in celiac disease-cereal gluten proteins-is known and the culprit HLA molecules are well defined. This has facilitated the dissection of the disease-relevant CD4+ T cells interacting with the disease-associated HLA molecules. In addition, celiac disease has distinct antibody responses to gluten and the autoantigen transglutaminase 2, which give strong handles to understand all sides of the adaptive immune response leading to disease. Here we review recent developments in the understanding of the role of T cells, B cells, and antigen-presenting cells in the pathogenic immune response of this instructive disorder.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22535446     DOI: 10.1007/s00281-012-0314-z

Source DB:  PubMed          Journal:  Semin Immunopathol        ISSN: 1863-2297            Impact factor:   9.623


  161 in total

1.  T cells from celiac disease lesions recognize gliadin epitopes deamidated in situ by endogenous tissue transglutaminase.

Authors:  O Molberg; S McAdam; K E Lundin; C Kristiansen; H Arentz-Hansen; K Kett; L M Sollid
Journal:  Eur J Immunol       Date:  2001-05       Impact factor: 5.532

2.  HLA in coeliac disease families: a novel test of risk modification by the 'other' haplotype when at least one DQA1*05-DQB1*02 haplotype is carried.

Authors:  A S Louka; S Nilsson; M Olsson; B Talseth; B A Lie; J Ek; A H Gudjónsdóttir; H Ascher; L M Sollid
Journal:  Tissue Antigens       Date:  2002-08

3.  A structural and immunological basis for the role of human leukocyte antigen DQ8 in celiac disease.

Authors:  Kate N Henderson; Jason A Tye-Din; Hugh H Reid; Zhenjun Chen; Natalie A Borg; Tim Beissbarth; Arthur Tatham; Stuart I Mannering; Anthony W Purcell; Nadine L Dudek; David A van Heel; James McCluskey; Jamie Rossjohn; Robert P Anderson
Journal:  Immunity       Date:  2007-07-12       Impact factor: 31.745

4.  Positive serum antigliadin antibodies without celiac disease in the elderly population: does it matter?

Authors:  Anitta Ruuskanen; Katri Kaukinen; Pekka Collin; Heini Huhtala; Raisa Valve; Markku Mäki; Liisa Luostarinen
Journal:  Scand J Gastroenterol       Date:  2010-10       Impact factor: 2.423

5.  Direct evidence of monocyte recruitment to inflammatory bowel disease mucosa.

Authors:  M C Grimm; W E Pullman; G M Bennett; P J Sullivan; P Pavli; W F Doe
Journal:  J Gastroenterol Hepatol       Date:  1995 Jul-Aug       Impact factor: 4.029

6.  The thiol redox state of lymphoid organs is modified by immunization: role of different immune cell populations.

Authors:  Patrizia Castellani; Giovanna Angelini; Laura Delfino; Andrea Matucci; Anna Rubartelli
Journal:  Eur J Immunol       Date:  2008-09       Impact factor: 5.532

7.  Endomysium antibodies in coeliac disease: an improved method.

Authors:  B Ladinser; E Rossipal; K Pittschieler
Journal:  Gut       Date:  1994-06       Impact factor: 23.059

8.  In celiac disease, a subset of autoantibodies against transglutaminase binds toll-like receptor 4 and induces activation of monocytes.

Authors:  Giovanna Zanoni; Riccardo Navone; Claudio Lunardi; Giuseppe Tridente; Caterina Bason; Simona Sivori; Ruggero Beri; Marzia Dolcino; Enrico Valletta; Roberto Corrocher; Antonio Puccetti
Journal:  PLoS Med       Date:  2006-09       Impact factor: 11.069

9.  Gliadin-specific, HLA-DQ(alpha 1*0501,beta 1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients.

Authors:  K E Lundin; H Scott; T Hansen; G Paulsen; T S Halstensen; O Fausa; E Thorsby; L M Sollid
Journal:  J Exp Med       Date:  1993-07-01       Impact factor: 14.307

10.  Shared and distinct genetic variants in type 1 diabetes and celiac disease.

Authors:  Deborah J Smyth; Vincent Plagnol; Neil M Walker; Jason D Cooper; Kate Downes; Jennie H M Yang; Joanna M M Howson; Helen Stevens; Ross McManus; Cisca Wijmenga; Graham A Heap; Patrick C Dubois; David G Clayton; Karen A Hunt; David A van Heel; John A Todd
Journal:  N Engl J Med       Date:  2008-12-10       Impact factor: 91.245

View more
  21 in total

Review 1.  Food allergy in irritable bowel syndrome: The case of non-celiac wheat sensitivity.

Authors:  Pasquale Mansueto; Alberto D'Alcamo; Aurelio Seidita; Antonio Carroccio
Journal:  World J Gastroenterol       Date:  2015-06-21       Impact factor: 5.742

Review 2.  Clinical implications of shared genetics and pathogenesis in autoimmune diseases.

Authors:  Alexandra Zhernakova; Sebo Withoff; Cisca Wijmenga
Journal:  Nat Rev Endocrinol       Date:  2013-08-20       Impact factor: 43.330

3.  Immune Toxicities Elicted by CTLA-4 Blockade in Cancer Patients Are Associated with Early Diversification of the T-cell Repertoire.

Authors:  David Y Oh; Jason Cham; Li Zhang; Grant Fong; Serena S Kwek; Mark Klinger; Malek Faham; Lawrence Fong
Journal:  Cancer Res       Date:  2016-12-28       Impact factor: 12.701

4.  Soluble Syndecan-1: A Novel Biomarker of Small Bowel Mucosal Damage in Children with Celiac Disease.

Authors:  D Yablecovitch; A Oren; S Ben-Horin; E Fudim; R Eliakim; T Saker; F M Konikoff; U Kopylov; T Matthias; A Lerner
Journal:  Dig Dis Sci       Date:  2016-12-26       Impact factor: 3.199

Review 5.  The genetics of human autoimmune disease: A perspective on progress in the field and future directions.

Authors:  Michael F Seldin
Journal:  J Autoimmun       Date:  2015-09-04       Impact factor: 7.094

6.  Markers of Celiac Disease and Gluten Sensitivity in Children with Autism.

Authors:  Nga M Lau; Peter H R Green; Annette K Taylor; Dan Hellberg; Mary Ajamian; Caroline Z Tan; Barry E Kosofsky; Joseph J Higgins; Anjali M Rajadhyaksha; Armin Alaedini
Journal:  PLoS One       Date:  2013-06-18       Impact factor: 3.240

Review 7.  Assessing of Celiac Disease and Nonceliac Gluten Sensitivity.

Authors:  N Ontiveros; M Y Hardy; F Cabrera-Chavez
Journal:  Gastroenterol Res Pract       Date:  2015-04-29       Impact factor: 2.260

8.  Transglutaminase 2-specific autoantibodies in celiac disease target clustered, N-terminal epitopes not displayed on the surface of cells.

Authors:  Rasmus Iversen; Roberto Di Niro; Jorunn Stamnaes; Knut E A Lundin; Patrick C Wilson; Ludvig M Sollid
Journal:  J Immunol       Date:  2013-05-20       Impact factor: 5.422

9.  Contrasting the Genetic Background of Type 1 Diabetes and Celiac Disease Autoimmunity.

Authors:  Javier Gutierrez-Achury; Jihane Romanos; Sjoerd F Bakker; Vinod Kumar; Esther C de Haas; Gosia Trynka; Isis Ricaño-Ponce; Andrea Steck; Wei-Min Chen; Suna Onengut-Gumuscu; Suat Simsek; Marian Rewers; Chris J Mulder; Ed Liu; Stephen S Rich; Cisca Wijmenga
Journal:  Diabetes Care       Date:  2015-10       Impact factor: 19.112

10.  Role of CXCR3/CXCL10 axis in immune cell recruitment into the small intestine in celiac disease.

Authors:  Constanza Bondar; Romina E Araya; Luciana Guzman; Eduardo Cueto Rua; Nestor Chopita; Fernando G Chirdo
Journal:  PLoS One       Date:  2014-02-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.